Hepatitis C Virus Retreatment Successful with SOF/VEL/VOX in Patients With and Without HIV
November 13th 2018A fixed-dose combination therapy (Vosevi, Gilead) was highly effective after 12 weeks in retreating direct-acting antiviral-experienced patients with hepatitis C virus infection, with and without HIV co-infection, including those with prior noncompletion of treatment or poor adherence.